AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, presented two posters during the 2025 ...

Patient-reported outcomes (PROs) were similar among those treated with tivozanib monotherapy and those given combination ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

Radium-223 re-treatment is safe for metastatic castration-resistant prostate cancer, per findings from the 2025 ASCO GU ...

Tivozanib plus nivolumab had similar patient-reported outcomes to tivozanib alone in advanced kidney cancer after prior ...

Symptom scores remained stable over time, with similar QOL trends in both treatment arms.

The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S.

The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its ...

Health systems are facing hurdles to implementing new and effective metastatic urothelial carcinoma (mUC) therapies into ...

Tim Mitnik calls for immediate action to protect student nurses and other nursing staff from the violence they experience in ...

Data show Anaphylm maintains consistent stability and potency under extreme temperature and real-world conditions, including heat, freezing, and ...

Our findings show that Decipher Prostate test results can provide physicians with important information to help guide treatment decision-making with their patients.” Poster (Abstract #831): A ...